$OREX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Orexigen Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Orexigen Therapeutics, Inc.. Get notifications about new insider transactions in Orexigen Therapeutics, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 10 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 29 2008 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Business Offi ... | Option Exercise | M | 0.10 | 13,664 | 1,366 | 122,291 | |
Aug 29 2008 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Business Offi ... | Sell | S | 12.00 | 13,664 | 163,968 | 0 | 13.7 K to 0 (-100.00 %) |
Aug 29 2008 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Business Offi ... | Buy | M | 0.10 | 13,664 | 1,366 | 13,664 | 0 to 13.7 K |
Aug 29 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.05 | 100 | 1,205 | 31,255 | 31.4 K to 31.3 K (-0.32 %) |
Aug 29 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.05 | 200 | 2,410 | 31,355 | 31.6 K to 31.4 K (-0.63 %) |
Aug 29 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.05 | 1,800 | 21,682 | 454,848 | 456.6 K to 454.8 K (-0.39 %) |
Aug 29 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.05 | 3,300 | 39,772 | 456,648 | 459.9 K to 456.6 K (-0.72 %) |
Aug 29 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.05 | 8,900 | 107,205 | 2,295,851 | 2.3 M to 2.3 M (-0.39 %) |
Aug 29 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.05 | 16,500 | 198,858 | 2,304,751 | 2.3 M to 2.3 M (-0.71 %) |
Aug 27 2008 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Business Offi ... | Option Exercise | M | 0.10 | 3,000 | 300 | 135,955 | |
Aug 27 2008 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Business Offi ... | Sell | S | 12.02 | 3,000 | 36,060 | 0 | 3 K to 0 (-100.00 %) |
Aug 27 2008 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Business Offi ... | Buy | M | 0.10 | 3,000 | 300 | 3,000 | 0 to 3 K |
Aug 27 2008 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Option Exercise | M | 2.00 | 40,000 | 80,000 | 200,000 | |
Aug 27 2008 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 11.28 | 40,000 | 451,200 | 0 | 40 K to 0 (-100.00 %) |
Aug 27 2008 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Buy | M | 2.00 | 40,000 | 80,000 | 40,000 | 0 to 40 K |
Aug 25 2008 | OREX | Orexigen Therapeut ... | BYMASTER FRANKLIN P | VP, Neuroscience | Option Exercise | M | 2.00 | 1,800 | 3,600 | 19,959 | |
Aug 25 2008 | OREX | Orexigen Therapeut ... | BYMASTER FRANKLIN P | VP, Neuroscience | Option Exercise | M | 2.00 | 3,241 | 6,482 | 21,759 | |
Aug 25 2008 | OREX | Orexigen Therapeut ... | BYMASTER FRANKLIN P | VP, Neuroscience | Sell | S | 12.00 | 1,800 | 21,600 | 0 | 1.8 K to 0 (-100.00 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | BYMASTER FRANKLIN P | VP, Neuroscience | Buy | M | 2.00 | 1,800 | 3,600 | 1,800 | 0 to 1.8 K |
Aug 25 2008 | OREX | Orexigen Therapeut ... | BYMASTER FRANKLIN P | VP, Neuroscience | Sell | S | 12.00 | 3,241 | 38,892 | 0 | 3.2 K to 0 (-100.00 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | BYMASTER FRANKLIN P | VP, Neuroscience | Buy | M | 2.00 | 3,241 | 6,482 | 3,241 | 0 to 3.2 K |
Aug 25 2008 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Option Exercise | M | 0.70 | 8,259 | 5,781 | 246,685 | |
Aug 25 2008 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 12.00 | 8,259 | 99,108 | 0 | 8.3 K to 0 (-100.00 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Buy | M | 0.70 | 8,259 | 5,781 | 8,259 | 0 to 8.3 K |
Aug 25 2008 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Option Exercise | M | 2.00 | 8,259 | 16,518 | 231,741 | |
Aug 25 2008 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 12.00 | 8,259 | 99,108 | 0 | 8.3 K to 0 (-100.00 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Buy | M | 2.00 | 8,259 | 16,518 | 8,259 | 0 to 8.3 K |
Aug 25 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.00 | 100 | 1,200 | 31,555 | 31.7 K to 31.6 K (-0.32 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.00 | 100 | 1,200 | 31,655 | 31.8 K to 31.7 K (-0.31 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.00 | 800 | 9,602 | 459,948 | 460.7 K to 459.9 K (-0.17 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.00 | 800 | 9,600 | 460,748 | 461.5 K to 460.7 K (-0.17 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.00 | 3,900 | 46,810 | 2,321,251 | 2.3 M to 2.3 M (-0.17 %) |
Aug 25 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Sell | S | 12.00 | 4,400 | 52,800 | 2,325,151 | 2.3 M to 2.3 M (-0.19 %) |
Aug 18 2008 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Option Exercise | A | 11.34 | 40,000 | 453,600 | 40,000 | |
Aug 18 2008 | OREX | Orexigen Therapeut ... | BYMASTER FRANKLIN P | VP, Neuroscience | Option Exercise | A | 11.34 | 10,000 | 113,400 | 10,000 | |
Aug 18 2008 | OREX | Orexigen Therapeut ... | Turner Heather D | VP, Gen. Counsel & ... | Option Exercise | A | 11.34 | 100,000 | 1,134,000 | 100,000 | |
Aug 18 2008 | OREX | Orexigen Therapeut ... | COWLEY MICHAEL A | Chief Scientific Of ... | Option Exercise | A | 11.34 | 25,000 | 283,500 | 25,000 | |
Aug 18 2008 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Option Exercise | A | 11.34 | 120,000 | 1,360,800 | 120,000 | |
Aug 18 2008 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Business Offi ... | Option Exercise | A | 11.34 | 50,000 | 567,000 | 50,000 | |
Aug 18 2008 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Option Exercise | A | 11.34 | 110,000 | 1,247,400 | 110,000 | |
Aug 18 2008 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Option Exercise | A | 11.34 | 310,000 | 3,515,400 | 310,000 | |
Jun 13 2008 | OREX | Orexigen Therapeut ... | BOCK LOUIS C | Director | Option Exercise | A | 8.18 | 25,000 | 204,500 | 25,000 | |
Jun 12 2008 | OREX | Orexigen Therapeut ... | WEBER ECKARD | Director | Option Exercise | A | 8.18 | 25,000 | 204,500 | 25,000 | |
Jun 12 2008 | OREX | Orexigen Therapeut ... | DOVEY BRIAN H | Director | Option Exercise | A | 8.18 | 25,000 | 204,500 | 25,000 | |
Jun 12 2008 | OREX | Orexigen Therapeut ... | LACOB JOSEPH | Director | Option Exercise | A | 8.18 | 25,000 | 204,500 | 25,000 | |
Jun 12 2008 | OREX | Orexigen Therapeut ... | POWELL MICHAEL | Director | Option Exercise | A | 8.18 | 25,000 | 204,500 | 25,000 | |
Jun 12 2008 | OREX | Orexigen Therapeut ... | TURNER DANIEL K III | Director | Option Exercise | A | 8.18 | 25,000 | 204,500 | 25,000 | |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANCASTER JAMES C JR | VP of Commercial Op ... | Option Exercise | M | 2.00 | 3,000 | 6,000 | 31,500 | |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANCASTER JAMES C JR | VP of Commercial Op ... | Sell | S | 15.10 | 500 | 7,550 | 0 | 500 to 0 (-100.00 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANCASTER JAMES C JR | VP of Commercial Op ... | Sell | S | 15.07 | 19 | 286 | 500 | 519 to 500 (-3.66 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANCASTER JAMES C JR | VP of Commercial Op ... | Sell | S | 15.05 | 481 | 7,239 | 519 | 1,000 to 519 (-48.10 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANCASTER JAMES C JR | VP of Commercial Op ... | Sell | S | 15.00 | 542 | 8,130 | 1,000 | 1.5 K to 1,000 (-35.15 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANCASTER JAMES C JR | VP of Commercial Op ... | Sell | S | 14.90 | 1,458 | 21,724 | 1,542 | 3 K to 1.5 K (-48.60 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANCASTER JAMES C JR | VP of Commercial Op ... | Buy | M | 2.00 | 3,000 | 6,000 | 3,000 | 0 to 3 K |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Option Exercise | M | 2.00 | 5,000 | 10,000 | 240,000 | |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 15.10 | 820 | 12,382 | 0 | 820 to 0 (-100.00 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 15.07 | 32 | 482 | 820 | 852 to 820 (-3.76 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 15.05 | 788 | 11,859 | 852 | 1.6 K to 852 (-48.05 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 15.00 | 888 | 13,320 | 1,640 | 2.5 K to 1.6 K (-35.13 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 14.90 | 2,472 | 36,833 | 2,528 | 5 K to 2.5 K (-49.44 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Buy | M | 2.00 | 5,000 | 10,000 | 5,000 | 0 to 5 K |
Dec 28 2007 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Operating Off ... | Option Exercise | M | 0.10 | 4,166 | 417 | 138,955 | |
Dec 28 2007 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Operating Off ... | Sell | S | 15.10 | 680 | 10,268 | 0 | 680 to 0 (-100.00 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Operating Off ... | Sell | S | 15.07 | 27 | 407 | 680 | 707 to 680 (-3.82 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Operating Off ... | Sell | S | 15.05 | 653 | 9,828 | 707 | 1.4 K to 707 (-48.01 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Operating Off ... | Sell | S | 15.00 | 736 | 11,040 | 1,360 | 2.1 K to 1.4 K (-35.11 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Operating Off ... | Sell | S | 14.90 | 2,070 | 30,843 | 2,096 | 4.2 K to 2.1 K (-49.69 %) |
Dec 28 2007 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Operating Off ... | Buy | M | 0.10 | 4,166 | 417 | 4,166 | 0 to 4.2 K |
Dec 26 2007 | OREX | Orexigen Therapeut ... | Turner Heather D | Vice President | Option Exercise | A | 14.26 | 16,000 | 228,160 | 16,000 | |
Dec 26 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Option Exercise | A | 14.26 | 80,000 | 1,140,800 | 80,000 | |
Dec 26 2007 | OREX | Orexigen Therapeut ... | MCKINNEY ANTHONY A | Chief Operating Off ... | Option Exercise | A | 14.26 | 45,000 | 641,700 | 45,000 | |
Dec 26 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Option Exercise | A | 14.26 | 20,000 | 285,200 | 20,000 | |
Dec 26 2007 | OREX | Orexigen Therapeut ... | LANCASTER JAMES C JR | VP of Commercial Op ... | Option Exercise | A | 14.26 | 5,000 | 71,300 | 5,000 | |
Dec 26 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Option Exercise | A | 14.26 | 47,000 | 670,220 | 47,000 | |
Dec 26 2007 | OREX | Orexigen Therapeut ... | COWLEY MICHAEL A | Chief Scientific Of ... | Option Exercise | A | 14.26 | 10,000 | 142,600 | 10,000 | |
Dec 26 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Option Exercise | A | 14.26 | 45,000 | 641,700 | 45,000 | |
Dec 26 2007 | OREX | Orexigen Therapeut ... | BYMASTER FRANKLIN P | VP of Neuroscience | Option Exercise | A | 14.26 | 4,000 | 57,040 | 4,000 | |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Option Exercise | M | 2.00 | 5,000 | 10,000 | 240,000 | |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.15 | 556 | 7,867 | 0 | 556 to 0 (-100.00 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.14 | 56 | 792 | 556 | 612 to 556 (-9.15 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.13 | 111 | 1,568 | 612 | 723 to 612 (-15.35 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.12 | 112 | 1,581 | 723 | 835 to 723 (-13.41 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.11 | 83 | 1,171 | 835 | 918 to 835 (-9.04 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.10 | 1,389 | 19,585 | 918 | 2.3 K to 918 (-60.21 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.09 | 508 | 7,158 | 2,307 | 2.8 K to 2.3 K (-18.05 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.08 | 556 | 7,828 | 2,815 | 3.4 K to 2.8 K (-16.49 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.07 | 544 | 7,654 | 3,371 | 3.9 K to 3.4 K (-13.90 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.06 | 529 | 7,438 | 3,915 | 4.4 K to 3.9 K (-11.90 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Sell | S | 14.05 | 556 | 7,812 | 4,444 | 5 K to 4.4 K (-11.12 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | DUNAYEVICH EDUARDO | Chief Medical Offic ... | Buy | M | 2.00 | 5,000 | 10,000 | 5,000 | 0 to 5 K |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Option Exercise | M | 0.70 | 4,000 | 2,800 | 254,944 | |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.15 | 444 | 6,283 | 0 | 444 to 0 (-100.00 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.14 | 44 | 622 | 444 | 488 to 444 (-9.02 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.13 | 88 | 1,243 | 488 | 576 to 488 (-15.28 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.12 | 90 | 1,271 | 576 | 666 to 576 (-13.51 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.11 | 67 | 945 | 666 | 733 to 666 (-9.14 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.10 | 1,110 | 15,651 | 733 | 1.8 K to 733 (-60.23 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.09 | 412 | 5,805 | 1,843 | 2.3 K to 1.8 K (-18.27 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.08 | 444 | 6,252 | 2,255 | 2.7 K to 2.3 K (-16.45 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.07 | 436 | 6,135 | 2,699 | 3.1 K to 2.7 K (-13.91 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.06 | 421 | 5,919 | 3,135 | 3.6 K to 3.1 K (-11.84 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Sell | S | 14.05 | 444 | 6,238 | 3,556 | 4 K to 3.6 K (-11.10 %) |
Dec 21 2007 | OREX | Orexigen Therapeut ... | COOPER GRAHAM K | CFO and Treasurer | Buy | M | 0.70 | 4,000 | 2,800 | 4,000 | 0 to 4 K |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Option Exercise | M | 0.60 | 15,000 | 9,000 | 840,883 | |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.35 | 1,000 | 14,350 | 0 | 1,000 to 0 (-100.00 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.34 | 1,000 | 14,340 | 1,000 | 2 K to 1,000 (-50.00 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.33 | 2,000 | 28,660 | 2,000 | 4 K to 2 K (-50.00 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.30 | 1,000 | 14,300 | 4,000 | 5 K to 4 K (-20.00 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.29 | 1,000 | 14,290 | 5,000 | 6 K to 5 K (-16.67 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.27 | 4,000 | 57,080 | 6,000 | 10 K to 6 K (-40.00 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.26 | 3,000 | 42,780 | 10,000 | 13 K to 10 K (-23.08 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.25 | 1,000 | 14,250 | 13,000 | 14 K to 13 K (-7.14 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Sell | S | 14.15 | 1,000 | 14,150 | 14,000 | 15 K to 14 K (-6.67 %) |
Dec 19 2007 | OREX | Orexigen Therapeut ... | TOLLEFSON GARY D | President and CEO | Buy | M | 0.60 | 15,000 | 9,000 | 15,000 | 0 to 15 K |
Dec 19 2007 | OREX | Orexigen Therapeut ... | WEBER ECKARD | Director | Gift | G | 0.00 | 810,000 | 0 | 810,000 | 0 to 810 K |
Dec 19 2007 | OREX | Orexigen Therapeut ... | WEBER ECKARD | Director | Gift | G | 0.00 | 810,000 | 0 | 0 | 810 K to 0 (-100.00 %) |
Nov 30 2007 | OREX | Orexigen Therapeut ... | COWLEY MICHAEL A | Chief Scientific Of ... | Sell | S | 14.40 | 4,156 | 59,846 | 181,344 | 185.5 K to 181.3 K (-2.24 %) |
Nov 30 2007 | OREX | Orexigen Therapeut ... | COWLEY MICHAEL A | Chief Scientific Of ... | Sell | S | 14.35 | 7,500 | 107,625 | 185,500 | 193 K to 185.5 K (-3.89 %) |
Nov 30 2007 | OREX | Orexigen Therapeut ... | COWLEY MICHAEL A | Chief Scientific Of ... | Sell | S | 14.30 | 5,000 | 71,500 | 193,000 | 198 K to 193 K (-2.53 %) |
Nov 30 2007 | OREX | Orexigen Therapeut ... | COWLEY MICHAEL A | Chief Scientific Of ... | Sell | S | 14.25 | 10,000 | 142,500 | 198,000 | 208 K to 198 K (-4.81 %) |
Nov 30 2007 | OREX | Orexigen Therapeut ... | COWLEY MICHAEL A | Chief Scientific Of ... | Sell | S | 14.20 | 7,500 | 106,500 | 208,000 | 215.5 K to 208 K (-3.48 %) |
Nov 30 2007 | OREX | Orexigen Therapeut ... | COWLEY MICHAEL A | Chief Scientific Of ... | Sell | S | 14.15 | 1,000 | 14,150 | 215,500 | 216.5 K to 215.5 K (-0.46 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | DOMAIN PARTNERS V LP | 10% Owner | Sell | J | 0.00 | 900,000 | 0 | 3,543,832 | 4.4 M to 3.5 M (-20.25 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | MORE ROBERT J | 10% Owner | Sell | S | 14.27 | 21,000 | 299,670 | 83,975 | 105 K to 84 K (-20.00 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | MORE ROBERT J | 10% Owner | Buy | J | 0.00 | 16,606 | 0 | 16,606 | 0 to 16.6 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | MORE ROBERT J | 10% Owner | Buy | J | 0.00 | 1,963 | 0 | 1,963 | 0 to 2 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | MORE ROBERT J | 10% Owner | Sell | J | 0.00 | 900,000 | 0 | 3,543,832 | 4.4 M to 3.5 M (-20.25 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | DP V ASSOCIATES LP | 10% Owner | Sell | S | 14.27 | 21,000 | 299,670 | 83,975 | 105 K to 84 K (-20.00 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Sell | S | 14.27 | 21,000 | 299,670 | 83,975 | 105 K to 84 K (-20.00 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | J | 0.00 | 19,373 | 0 | 19,373 | 0 to 19.4 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | J | 0.00 | 1,963 | 0 | 1,963 | 0 to 2 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Sell | J | 0.00 | 900,000 | 0 | 3,543,832 | 4.4 M to 3.5 M (-20.25 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | SCHOEMAKER KATHLEEN K | 10% Owner | Sell | S | 14.27 | 21,000 | 299,670 | 83,975 | 105 K to 84 K (-20.00 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | J | 0.00 | 9,058 | 0 | 9,058 | 0 to 9.1 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | J | 0.00 | 1,963 | 0 | 1,963 | 0 to 2 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | SCHOEMAKER KATHLEEN K | 10% Owner | Sell | J | 0.00 | 900,000 | 0 | 3,543,832 | 4.4 M to 3.5 M (-20.25 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | J | 0.00 | 14,090 | 0 | 14,090 | 0 to 14.1 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Sell | S | 14.27 | 21,000 | 299,670 | 83,975 | 105 K to 84 K (-20.00 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | J | 0.00 | 15,096 | 0 | 15,096 | 0 to 15.1 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | J | 0.00 | 1,963 | 0 | 1,963 | 0 to 2 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Sell | J | 0.00 | 900,000 | 0 | 3,543,832 | 4.4 M to 3.5 M (-20.25 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | DOVEY BRIAN H | Director | Sell | S | 14.27 | 21,000 | 299,670 | 83,975 | 105 K to 84 K (-20.00 %) |
Nov 29 2007 | OREX | Orexigen Therapeut ... | DOVEY BRIAN H | Director | Buy | J | 0.00 | 20,128 | 0 | 20,128 | 0 to 20.1 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | DOVEY BRIAN H | Director | Buy | J | 0.00 | 1,963 | 0 | 1,963 | 0 to 2 K |
Nov 29 2007 | OREX | Orexigen Therapeut ... | DOVEY BRIAN H | Director | Sell | J | 0.00 | 900,000 | 0 | 3,543,832 | 4.4 M to 3.5 M (-20.25 %) |
Nov 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Option Exercise | M | 2.00 | 5,000 | 10,000 | 245,000 | |
Nov 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 14.56 | 123 | 1,791 | 0 | 123 to 0 (-100.00 %) |
Nov 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 14.55 | 82 | 1,193 | 123 | 205 to 123 (-40.00 %) |
Nov 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 14.47 | 41 | 593 | 205 | 246 to 205 (-16.67 %) |
Nov 28 2007 | OREX | Orexigen Therapeut ... | LANDBLOOM RONALD P | VP, Medical and Reg ... | Sell | S | 14.45 | 369 | 5,332 | 246 | 615 to 246 (-60.00 %) |